M&A/Corporate Transactions | Healthcare and Life Sciences | Legal Services

About

Our cross-border M&A team is particularly skilled in transactions pertaining to the healthcare industry and boasts an unparalleled track record in acting for foreign companies in their acquisitions of Japanese companies and in the local integration of US and European companies’ Japanese entities involved in cross-border acquisitions. The M&A group also fields lawyers with expertise in MBOs, private equity, corporate restructuring and insolvency. We are also Japan’s leading law firm in advising international clients on joint ventures, business collaborations and cross-border alliances, corporate restructuring and reorganization.

Representative Experience

Assisted an international pharmaceutical company in establishing a joint venture with a Japanese pharmaceutical company to enter the Japanese market.
Advised an international medical device manufacturer on the acquisition of Japanese competitors.
Advised an international conglomerate on a strategic alliance and on the acquisition of shares in Japanese healthcare companies.
Advised an international pharmaceutical company and its Japanese subsidiary on their post-merger integration with the Japan entities of another international pharmaceutical company following their global merger.
Advised an international healthcare company with respect to the Japanese aspects of a global separation and spin-off of its research-based pharmaceutical business and on the formation of a new publicly-traded biopharmaceutical company.
Advised a Japanese medical device manufacturer on its acquisition of the Continuous Renal Replacement Therapy (CRRT) business from a US healthcare corporation.